Elicio Therapeutics, Inc. (ELTX)
2.56
-0.14
(-5.19%)
USD |
NASDAQ |
Sep 01, 16:00
2.56
0.00 (0.00%)
After-Hours: 20:00
Elicio Therapeutics Total Long Term Debt (Quarterly) : 13.08M for June 30, 2026
Total Long Term Debt (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Long Term Debt (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.08M |
| March 31, 2026 | 13.30M |
| December 31, 2025 | 13.50M |
| September 30, 2025 | 14.08M |
| June 30, 2025 | 13.95M |
| March 31, 2025 | 4.865M |
| December 31, 2024 | 25.14M |
| September 30, 2024 | 25.17M |
| June 30, 2024 | 5.565M |
| March 31, 2024 | 5.791M |
| December 31, 2023 | 6.007M |
| September 30, 2023 | 6.215M |
| June 30, 2023 | 6.419M |
| March 31, 2023 | 0.07M |
| Date | Value |
|---|---|
| December 31, 2022 | 6.789M |
| September 30, 2022 | 2.988M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 3.515M |
| December 31, 2021 | 3.768M |
| September 30, 2021 | 3.706M |
| June 30, 2021 | 3.932M |
| March 31, 2021 | 4.15M |
| December 31, 2020 | 55.65M |
| September 30, 2020 | 4.641M |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 9.745M |
Total Long Term Debt Definition
Represents a company's total debt maturing for more than 12 months of the reporting period.
Total Long Term Debt (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Long Term Debt (Quarterly) Benchmarks
| Precigen, Inc. | 97.29M |
| Agenus, Inc. | 259.00M |
| Amgen, Inc. | 57.30B |
| Anika Therapeutics, Inc. | 23.32M |
| BioCryst Pharmaceuticals, Inc. | 834.73M |